PHM7D Stock Overview
Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 6/6 |
Altria Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$49.78 |
| 52 Week High | US$49.87 |
| 52 Week Low | US$36.17 |
| Beta | 0.68 |
| 11 Month Change | 8.67% |
| 3 Month Change | 12.51% |
| 1 Year Change | 30.76% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 15.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHM7D | GB Tobacco | GB Market | |
|---|---|---|---|
| 7D | 7.9% | 2.1% | -0.9% |
| 1Y | 30.8% | 11.7% | 8.6% |
Return vs Industry: PHM7D exceeded the UK Tobacco industry which returned 11.5% over the past year.
Return vs Market: PHM7D exceeded the UK Market which returned 10.2% over the past year.
Price Volatility
| PHM7D volatility | |
|---|---|
| PHM7D Average Weekly Movement | n/a |
| Tobacco Industry Average Movement | 2.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PHM7D's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine PHM7D's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1822 | 6,400 | Billy Gifford | www.altria.com |
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Altria Group, Inc. Fundamentals Summary
| PHM7D fundamental statistics | |
|---|---|
| Market cap | €85.17b |
| Earnings (TTM) | €9.47b |
| Revenue (TTM) | €18.79b |
8.9x
P/E Ratio4.5x
P/S RatioIs PHM7D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHM7D income statement (TTM) | |
|---|---|
| Revenue | US$20.36b |
| Cost of Revenue | US$6.16b |
| Gross Profit | US$14.20b |
| Other Expenses | US$3.94b |
| Earnings | US$10.26b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.05 |
| Gross Margin | 69.76% |
| Net Profit Margin | 50.39% |
| Debt/Equity Ratio | -736.0% |
How did PHM7D perform over the long term?
See historical performance and comparison